{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T15:36:40Z","timestamp":1777736200501,"version":"3.51.4"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Adrenomedullin (ADM), a multifunctional peptide, has been implicated in various inflammatory and autoimmune diseases. However, its role in cancer, particularly in NSCLC, remained under-explored. This called for a pan-cancer analysis of ADM, investigating its expression, genomic alterations, prognostic value, immune associations, and relations with drug sensitivity to provide insights into its potential as a therapeutic target and biomarker.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>ADM expression data from normal and tumor tissues was retrieved and analyzed through HPA and Timer 2.0 online platforms. Genetic alterations, copy number variations (CNVs), and methylation patterns were analyzed using cBioPortal and GSCA platforms. The data for survival analysis was extracted from TCGA and GEO database and analyzed through GEPIA and PrognoScan online platforms. ADM\u2019s correlations with immune checkpoint genes, immune cell infiltration, MSI, and TMB were evaluated using data from Timer and TCGA via R. Drug sensitivity analysis was performed with GDSC and CTRP databases, supported by network visualizations. IHC staining was conducted on LUAD patients\u2019 samples to assess ADM\u2019s relationship with EGFR-TKI resistance and immune microenvironment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>ADM was widely expressed across normal tissues, with high levels in adipose tissue, endocrine organs, digestive and reproductive systems. Pan-cancer analysis revealed that ADM expression was upregulated in multiple cancer types, including CESC, ESCA, GBM, HNSC, KICH, KIRC, LUSC, PCPG, THCA, and UCEC, and correlated with advanced pathological stages in THCA, KIRP, and HNSC. Furthermore, high ADM expression was significantly linked to poor prognosis in patients with LGG, LUAD, MESO, THYM, LIHC, HNSC, GBM, KICH, KIRP, CESC, PAAD, and STAD, while its negative influence on OS and RFS was validated in LUAD. In addition, ADM exhibited genetic alterations, including amplification and deep deletion across multiple cancer types. Strong and consistent positive correlations were witnessed between ADM and several immune checkpoint genes, including CD274 (PD-L1), CD276, TNFRSF18, TNFSF9, and PVR in pan-cancer analysis, indicating its role in the development of suppressive immune microenvironment and T cell exhaustion. Besides, ADM showed significant correlations with immune cell infiltration, and TMB\/MSI, highlighting its role in immune regulation and its potential as a predictive biomarker for immunotherapy. Significantly, ADM expression was correlated with multiple drug sensitivity, particularly chemotherapy and tyrosine kinase inhibitors (TKIs) therapy. Moreover, positive correlations between its expression and EGFR-TKI resistance, CD8<jats:sup>+<\/jats:sup> T cell infiltration and tumor proportion score (TPS) in LUAD were validated in patients\u2019 samples, emphasizing its potential in guiding personalized therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This pan-cancer analysis revealed ADM\u2019s pivotal role in progression, immune modulation, and therapeutic response, especially in LUAD. ADM held promise as a prognostic biomarker and a potential therapeutic target in immune modulation and resistance management. Future research should focus on experimental validation and elucidation of ADM-mediated pathways, which might provide novel insights into cancer biology and improve clinical outcomes<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1573250","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T05:23:30Z","timestamp":1748928210000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Integrated pan-cancer analysis of ADM\u2019s role in prognosis, immune modulation and resistance"],"prefix":"10.3389","volume":"16","author":[{"given":"Yunhuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caicun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/cac2.12505","article-title":"Management of locally advanced non-small cell lung cancer: State of the art and future directions","volume":"44","author":"Miao","year":"2024","journal-title":"Cancer Commun (Lond)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41572-024-00551-9","article-title":"Non-small-cell lung cancer","volume":"10","author":"Hendriks","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-024-02030-7","article-title":"Targeting KRAS(G12C) in non-small-cell lung cancer: current standards and developments","volume":"84","author":"Torres-Jim\u00e9nez","year":"2024","journal-title":"Drugs"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-022-00718-x","article-title":"At the crossroads of immunotherapy for oncogene-addicted subsets of NSCLC","volume":"20","author":"Otano","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12359.","article-title":"Non-small cell lung cancer in China","volume":"42","author":"Chen","year":"2022","journal-title":"Cancer Commun (Lond)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41392-022-01136-2","article-title":"Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13045-022-01391-4","article-title":"Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance","volume":"15","author":"Fu","year":"2022","journal-title":"J Hematol Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adi4777","article-title":"Adrenomedullin has a pivotal role in trophoblast differentiation: A promising nanotechnology-based therapeutic target for early-onset preeclampsia","volume":"9","author":"Zhang","year":"2023","journal-title":"Sci Adv"},{"key":"B9","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3390\/cells13110892","article-title":"A focus on the pathophysiology of adrenomedullin expression: endothelitis and organ damage in severe viral and bacterial infections","volume":"13","author":"Spoto","year":"2024","journal-title":"Cells"},{"key":"B10","doi-asserted-by":"publisher","first-page":"12795","DOI":"10.1038\/s41598-024-63412-1","article-title":"Postoperative bioactive adrenomedullin is associated with the onset of ARDS and adverse outcomes in patients undergoing open thoracoabdominal aortic surgery","volume":"14","author":"Doukas","year":"2024","journal-title":"Sci Rep"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3345\/cep.2024.01543","article-title":"Differential roles of IL-6 and adrenomedullin in early diagnosis and mortality predictions in late-onset neonatal sepsis","author":"dos Santos","year":"2024","journal-title":"Clin Exp Pediatr"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.3390\/ijms24043943","article-title":"Adrenomedullin Improves Hypertension and Vascular Remodeling partly through the Receptor-Mediated AMPK Pathway in Rats with Obesity-Related Hypertension","volume":"24","author":"Wang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"120238","DOI":"10.1016\/j.lfs.2021.120238","article-title":"Differential response to hypoxia in leiomyoma and myometrial cells","volume":"290","author":"Miyashita-Ishiwata","year":"2022","journal-title":"Life Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e14601","DOI":"10.1111\/cns.14601","article-title":"Identification and validation of a glycolysis-related taxonomy for improving outcomes in glioma","volume":"30","author":"Ying","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"B15","doi-asserted-by":"publisher","first-page":"131800","DOI":"10.1016\/j.ijbiomac.2024.131800","article-title":"Mineralised collagen regulated the secretion of adrenomedullin by macrophages to activate the PI3K\/AKT signalling pathway to promote bone defect repair","volume":"269","author":"Meng","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.bbi.2024.05.005","article-title":"Plasma proteomic biomarkers and the association between poor cardiovascular health and incident dementia: The UK Biobank study","volume":"119","author":"Beydoun","year":"2024","journal-title":"Brain Behav Immun"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/EJA.0000000000001662","article-title":"The value of bioactive adrenomedullin and dipeptidyl peptidase 3 to predict short-term unfavourable outcomes after cardiac surgery: A prospective cohort study","volume":"39","author":"van Lier","year":"2022","journal-title":"Eur J Anaesthesiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13613-016-0229-2","article-title":"Adrenomedullin: a marker of impaired hemodynamics, organ dysfunction, and poor prognosis in cardiogenic shock","volume":"7","author":"Tolppanen","year":"2017","journal-title":"Ann Intensive Care"},{"key":"B19","doi-asserted-by":"publisher","first-page":"7175","DOI":"10.3390\/ijms23137175","article-title":"A set of dysregulated target genes to reduce neuroinflammation at molecular level","volume":"23","author":"Massimini","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-018-1079-8","article-title":"Reduced adrenomedullin parallels microtubule dismantlement in frontotemporal lobar degeneration","volume":"55","author":"Ferrero","year":"2018","journal-title":"Mol Neurobiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s10194-024-01893-1","article-title":"Sex differences in expression of CGRP family of receptors and ligands in the rat trigeminal system","volume":"25","author":"Maddahi","year":"2024","journal-title":"J Headache Pain"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13110","article-title":"Plasma mid-regional pro-adrenomedullin: A biomarker of the ischemic penumbra in hyperacute stroke","volume":"33","author":"Ishiyama","year":"2023","journal-title":"Brain Pathol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"6142","DOI":"10.3390\/jcm13206142","article-title":"Adrenomedullin as a new prosperous biomarker in infections: current and future perspectives","volume":"13","author":"Trojan","year":"2024","journal-title":"J Clin Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1058235","article-title":"Effects of enrichment strategies on outcome of adrecizumab treatment in septic shock: Post-hoc analyses of the phase II adrenomedullin and outcome in septic shock 2 trial","volume":"9","author":"van Lier","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.684396","article-title":"Adrenomedullin expression characterizes leukemia stem cells and associates with an inflammatory signature in acute myeloid leukemia","volume":"11","author":"Simonetti","year":"2021","journal-title":"Front Oncol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41419-020-2391-6","article-title":"Helicobacter pylori-induced adrenomedullin modulates IFN-\u03b3-producing T-cell responses and contributes to gastritis","volume":"11","author":"Kong","year":"2020","journal-title":"Cell Death Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"110488","DOI":"10.1016\/j.intimp.2023.110488","article-title":"Intermedin (adrenomedullin 2) plays a protective role in sepsis by regulating T- and B-cell proliferation and activity","volume":"121","author":"Feng","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41419-022-04647-6","article-title":"Extracellular ATP promotes breast cancer chemoresistance via HIF-1\u03b1 signaling","volume":"13","author":"Yang","year":"2022","journal-title":"Cell Death Dis"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1126\/science.1262110","article-title":"The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans","volume":"348","year":"2015","journal-title":"Science"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discovery"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2022.129862","article-title":"Physiological, biochemical, and genomic elucidation of the Ensifer adhaerens M8 strain with simultaneous arsenic oxidation and chromium reduction","volume":"441","author":"Li","year":"2023","journal-title":"J Hazard Mater"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bty411","article-title":"GSCALite: A web server for gene set cancer analysis","volume":"34","author":"Liu","year":"2018","journal-title":"Bioinformatics"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx1090","article-title":"LinkedOmics: analyzing multi-omics data within and across 32 cancer types","volume":"46","author":"Vasaikar","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25189985","article-title":"The BRD4 inhibitor I-BET-762 reduces HO-1 expression in macrophages and the pancreas of mice","volume":"25","author":"Leal","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-20-3177","article-title":"Analyzing the key gene expression and prognostics values for acute myeloid leukemia","volume":"9","author":"Shi","year":"2020","journal-title":"Transl Cancer Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242316986","article-title":"Adhesion G protein-coupled receptor G2 promotes hepatocellular carcinoma progression and serves as a neutrophil-related prognostic biomarker","volume":"24","author":"Wu","year":"2023","journal-title":"CMLS Int J Mol Sci"},{"key":"B37","article-title":"The signature of immune-subtype specific driving transcription factors suggests potential drugs for refractory glioblastoma","volume":"13","author":"Chen","year":"2023","journal-title":"Am J Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252212159","article-title":"Select endocrine disorders and exosomes in early PDAC diagnosis","volume":"25","author":"Wlodarczyk","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgad068","article-title":"An integrated analysis identifies six molecular subtypes of pancreatic ductal adenocarcinoma revealing cellular and molecular landscape","volume":"44","author":"Li","year":"2023","journal-title":"Carcinogenesis"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e70460","DOI":"10.1111\/jcmm.70460","article-title":"Adrenomedullin inhibits the efficacy of combined immunotherapy and targeted therapy in biliary tract cancer by disrupting endothelial cell functions","volume":"29","author":"Xuan","year":"2025","journal-title":"J Cell Mol Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.2478\/jtim-2023-0091","article-title":"Adrenomedullin induces cisplatin chemoresistance in ovarian cancer through reprogramming of glucose metabolism","volume":"11","author":"Dou","year":"2023","journal-title":"J Transl Int Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-0115(03)00037-5","article-title":"Adrenomedullin and cancer","volume":"112","author":"Zudaire","year":"2003","journal-title":"Regul Pept"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2025.108834","article-title":"Adrenomedullin gene delivery rescues estrogen production in Leydig cells via the inhibition of TGF-\u03b21\/Smads signaling pathway","volume":"132","author":"Luo","year":"2025","journal-title":"Reprod Toxicol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1055\/a-1811-2164","article-title":"Associations of plasma bioactive adrenomedullin levels with cardiovascular risk factors in BRCA1\/2 mutation carriers","volume":"82","author":"Lammert","year":"2022","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.754784","article-title":"Circulating biomarkers and cardiac structure and function in rheumatoid arthritis","volume":"8","author":"Kobayashi","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2007.060596","article-title":"Adrenomedullin protects from experimental arthritis by down-regulating inflammation and Th1 response and inducing regulatory T cells","volume":"170","author":"Gonzalez-Rey","year":"2007","journal-title":"Am J Pathol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12112420","article-title":"Targeting sepsis: disease tolerance, immune resilience, and compartmentalized immunity","volume":"12","author":"Garduno","year":"2024","journal-title":"Biomedicines"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2012.03577.x","article-title":"Adrenomedullin, a neuropeptide with immunoregulatory properties induces semi-mature tolerogenic dendritic cells","volume":"136","author":"Rull\u00e9","year":"2012","journal-title":"Immunology"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2011.05.022","article-title":"Shared and separate functions of the RAMP-based adrenomedullin receptors","volume":"32","author":"Kuwasako","year":"2011","journal-title":"Peptides"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1093\/biolre\/ioab026","article-title":"Soluble fms-like tyrosine kinase-1 and angiotensin2 target calcitonin gene-related peptide family peptides in maternal vascular smooth muscle cells in pregnancy\u2020","volume":"104","author":"Chauhan","year":"2021","journal-title":"Biol Reprod"},{"key":"B51","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/ijc.22596","article-title":"Adrenomedullin is induced by hypoxia and enhances pancreatic cancer cell invasion","volume":"121","author":"Keleg","year":"2007","journal-title":"Int J Cancer"},{"key":"B52","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s41467-020-20717-9","article-title":"Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells","volume":"12","author":"Larrue","year":"2021","journal-title":"Nat Commun"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1573250\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T05:23:30Z","timestamp":1748928210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1573250\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":52,"alternative-id":["10.3389\/fimmu.2025.1573250"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1573250","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]},"article-number":"1573250"}}